July 20th 2023
Lorazepam, diazepam, midazolam, fentanyl, hydromorphone, morphine, ketorolac, epinephrine, diphenhydramine, and methylprednisolone were investigated in the study. Overall, the most common type of deviation was an underdose.
Earn CME Credits While Advancing Your Expertise in Internal Medicine
April 18-19, 2024
Register Now!
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Cases and Conversations™: Evidence-Based Approaches to Management of CKD in Your Patients with T2DM
September 25, 2024
Register Now!
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
3rd Annual International Congress on Pediatric Oncology
October 25, 2024
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Comprehensive Approaches to Creating Successful Sickle Cell Management Plans Across Patients’ Lifespans
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
IUDS, implants best birth control choices for teenagers
October 1st 2012Long-acting reversible contraception (LARC) is the best choice for preventing unintended pregnancies, rapid repeat pregnancies, and abortions among sexually active adolescents and should be the first-line recommendation by health care providers, according to the American College of Obstetricians and Gynecologists.
CDC reports steep drop in tobacco use by teenagers
August 23rd 2012Tobacco use by middle school students decreased by nearly half between 2000 and 2001—from 14.9% to 7.1%—and fell from 34.4% to 23.2% among high school students, according to the Centers for Disease Control and Prevention (CDC). How do you help to continue the downward trend? More >>
Safe sex progress stalls in teenagers
August 1st 2012Have efforts to reduce HIV-related risk behaviors among high school students been successful? The latest data from the Centers from Disease Control and Prevention show that teens are practicing safer sex, but progress has stalled over the past decade.
Misinformation limits teens' access to emergency contraception
March 29th 2012Although emergency contraception (EC) is safe, effective, and widely available, misinformation communicated by pharmacies to adolescents and their physicians can make it difficult for teens to obtain EC in a timely manner. Do you know how to counter the misinformation and help your patients access EC?
Low HPV vaccination rate could mean danger later for teenagers
September 1st 2011Pediatricians are in an ideal position to turn around the low rate of vaccination against human papillomavirus in teenaged girls, according to a new government study. Nearly two-thirds of American teenaged girls have yet to receive the recommended 3-dose vaccination. Here are some proven methods for getting them the protection they need.
Secondary Syphilis in a Teenage Boy
August 1st 2007This rash on a teenage boy's palms began on his hands and spread to his torso and upper and lower extremities over several days. He had no pain or pruritus. Two weeks before the lesions appeared, he had experienced fatigue, fever, and myalgia of 1 week's duration.
Erratum: Update on treatment of primary syphilis
September 1st 2006The July 2006 issue, which featured an update on STDs, included a case on primary syphilis in a teenager (page 427). Therapy with intramuscular penicillin G (weekly for 3 weeks) or ceftriaxone (daily for 2 weeks) was recommended. However, the CDC's newly published guidelines on STD treatment recommend therapy with a single intramuscular dose of 2.4 million units of penicillin G.1 If the patient is allergic to penicillin, the alternative is therapy with doxycycline (100 mg orally bid for 14 days) or tetracycline (500 mg qid for 14 days). Ceftriaxone is not a recommended treatment for syphilis.
Sexually Transmitted Diseases:A Photo Quiz
July 1st 2006Fourteen-year-old JT is worried. During health class last week, he learned about the different sexually transmitted infections as well as about testicular self-examination. While practicing his monthly testicular examination in the shower, he noticed that he had a number of small growths on his penis. On further questioning, JT insists that he has never been sexually active with another person.
Guest Commentary: Actually, Doctor, There's This One Thing . . .
March 1st 2006Your patient, Keith, is a 19-year-old college freshman who is currently on spring break following the successful completion of his midterm exams. You have known him since he was 9 years old and you are looking forward to hearing about his first few months away at school.
New evidence: Mental health problems in teenagers may be traceable to early-life stress
January 13th 2006Parents' complaints about sudden mood swings of teenagers are common, but new research shows that children who experience early-life stresses such as abuse, neglect, or loss of a parent have an increased risk in adolescence of behavioral and emotional disorders. The research, conducted on rhesus macaque monkeys at the Oregon National Primate Research Center at Oregon Health & Science University and at the University of Pittsburgh, suggests that adolescents who have been exposed to early-life stress have a greater incidence of developing an attachment disorder, attention deficit hyperactivity disorder, conduct disorder, anxiety, depression, suicide, drug abuse, and post-traumatic stress disorder.
Gene variant boosts schizophrenia risk in already highly vulnerable teenagers
November 4th 2005A study of adolescents who lack part of chromosome 22 could lead to identification of a gene suspected of a role in schizophrenia. Findings of that study appear in the November 2005 issue of Nature Neuroscience.Although youths with the 22q11.2 chromosomal deletion syndrome already have a nearly 30-fold higher-than-normal risk of schizophrenia, those who have one of two common sequence versions of the suspect gene are more prone to cognitive decline, psychosis, and frontal-lobe tissue loss by late adolescence. The genetic variant appears to make symptoms of the deletion syndrome worse by chronically boosting the chemical messenger dopamine to an excessive level in the prefrontal cortex during development.